Microdosing GLP-1 for autoimmune conditions is an emerging area of interest, with some practitioners maintaining patients on very low doses primarily for anti-inflammatory benefits rather than weight management
Additionally, all participants were classified as obese
It is geared more toward users who are focused on sustained weight loss, rather than those looking to shed pounds for a short-term goal, such as an upcoming event
Weeks 13 to 16: Reduce from 0.5 mg to 0.25 mg weekly
Moreover, Temu's pricing structure might not be suitable for all budgets
Furthermore, the dissociation rate with the receptor is slow, and the high affinity and slow dissociation with the receptor prolongs the time of pharmacological effect (58, 60)